MEDSKIN SOLUTIONS DR. SUWELACK
LIVE

Serial Number

79086501

Owner

DR. SUWELACK SKIN & HEALTH CARE AG

Attorney

Katrin Lewertoff

Filing Date

Jul 22, 2010

Add to watchlist:

No watchlists yet
View on USPTO

MEDSKIN SOLUTIONS DR. SUWELACK Trademark

Serial Number: 79086501 • Registration: 4284323

MEDSKIN SOLUTIONS DR. SUWELACK is a trademark filed by DR. SUWELACK SKIN & HEALTH CARE AG on July 22, 2010. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

DR. SUWELACK SKIN & HEALTH CARE AG (19 trademarks)

JOSEF-SUWELACK-STRASSE
BILLERBECK 48727 , DE

Entity Type: 03

MEDSKIN SOLUTIONS DR. SUWELACK AG (23 trademarks)

JOSEF-SUWELACK-STRASSE
48727 BILLERBECK , DE

Entity Type: 09

Trademark Details

Filing Date

July 22, 2010

Registration Date

February 5, 2013

Published for Opposition

November 20, 2012

Goods & Services

[ Pharmaceutical and veterinary preparations, namely, for the treatment and/or post-treatment of skin defects caused by treatments such as dermabrasion, laser treatment, kryotherapy, chemical peeling, microneedling; pharmaceutical and veterinary preparations, namely, for the treatment and/or post-treatment of dermatitis, skin pigmentation disease, psoriasis, eczema, skin inflammation, dry skin, acne, urticaria, rosacea, pruritus, erythema and allergic skin reactions; pharmaceutical and veterinary preparations, namely, for the repair, replacement, regeneration and reconstruction of soft and hard tissue, cartilage, tendons and bones; pharmaceutical and veterinary preparations for diagnostic purposes; pharmaceutical and veterinary preparations for use as dermal filler consisting of proteins, polysaccharides, collagen, alginates, hyaluronic acid, acrylic acids, polyacrylates, chitosan, carrageen, pectins, cellulose, cellulose derivatives, carboxymethylcellulose, other biopolymers in freeze dried form; ] [ chemical preparations for medical purposes, namely, for the treatment and/or post-treatment of skin defects caused by treatments such as dermabrasion, laser treatment, kryotherapy, chemical peeling, microneedling; chemical preparations for medical purposes, namely, for the treatment and/or post-treatment of dermatitis, skin pigmentation disease, psoriasis, eczema, skin inflammation, dry skin, acne, urticaria, rosacea, pruritus, erythema and allergic skin reactions; ] chemical preparations for medical purposes, namely, for the repair, replacement, regeneration and reconstruction of soft [ and hard ] tissue [, cartilage, tendons and bones; chemical preparations for medical purposes, namely, for diagnostic purposes; chemical preparations for medical purposes for use as dermal filler consisting of proteins, polysaccharides, collagen, alginates, hyaluronic acid, acrylic acids, polyacrylates, chitosan, carrageen, pectins, cellulose, cellulose derivatives, carboxymethylcellulose, other biopolymers in freeze dried form; sanitary preparations for medical purposes; dietetic substances for medical use, namely, dietary supplements for obesity and nutritional supplements, food for babies; freeze-dried pharmaceutical and veterinary preparations for use as dermal filler and tissue regeneration template consisting of proteins, polysaccharides, collagen, alginates, hyaluronic acid, acrylic acids, polyacrylates, chitosan, carrageen, pectins, cellulose, cellulose derivatives, carboxymethylcellulose, and other biopolymers; material for stopping teeth, dental wax; all-purpose disinfectants; preparations for destroying vermin; fungicides, herbicides; pharmaceutical and veterinary preparations, namely, for augmentation of soft and hard tissue; pharmaceutical and veterinary preparations for cell cultures, namely, nutritive substances for growing cell culture media, culture media for coating cell culture incubators for growing human or animal cells, water-unsoluble films and scaffolds as culture media for growing 2D and 3D cell cultures; chemical preparations for cell cultures, namely, nutritive substances for growing cell culture media, culture media for coating cell culture incubators for growing human or animal cells, water-unsoluble films and scaffolds as culture media for growing 2D and 3D cell cultures ]

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 4, 2024 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Jun 4, 2024 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jun 4, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 4, 2024 REAP
PARTIAL INVALIDATION PROCESSED BY THE IB
May 20, 2024 INNP
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Apr 18, 2024 INPS
INVALIDATION PROCESSED
Apr 18, 2024 INPC
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Apr 11, 2024 INPR
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 9, 2024 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Mar 9, 2024 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 9, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 9, 2024 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Mar 9, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Mar 9, 2024 COAR
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Aug 13, 2023 NA71
REGISTERED-SEC.71 ACCEPTED
Aug 11, 2023 71AG
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Aug 11, 2023 APRE
TEAS SECTION 71 RECEIVED
Jan 24, 2023 ES71
NEW REPRESENTATIVE AT IB RECEIVED
Sep 9, 2022 NREP
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Feb 5, 2022 REM4
INTERNATIONAL REGISTRATION RENEWED
Aug 6, 2020 RNWL
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
May 10, 2019 NA75
REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
May 10, 2019 C75A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
May 10, 2019 APRE
TEAS SECTION 71 & 15 RECEIVED
May 3, 2019 ES75
NEW REPRESENTATIVE AT IB RECEIVED
Feb 16, 2017 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Oct 12, 2013 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Sep 20, 2013 FICS
FINAL DISPOSITION PROCESSED
Sep 20, 2013 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
May 5, 2013 FICR
CHANGE OF NAME/ADDRESS REC'D FROM IB
Mar 16, 2013 ADCH
REGISTERED-PRINCIPAL REGISTER
Feb 5, 2013 R.PR
UNDELIVERABLE MAIL - NO ACTION TAKEN
Nov 26, 2012 UNDN
PUBLISHED FOR OPPOSITION
Nov 20, 2012 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Nov 4, 2012 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Oct 31, 2012 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Oct 31, 2012 OP2R
NOTICE OF PUBLICATION
Oct 31, 2012 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
Oct 17, 2012 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 16, 2012 CNSA
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Oct 16, 2012 ZZZX
UNDELIVERABLE MAIL - NO ACTION TAKEN
Sep 25, 2012 UNDN
WITHDRAWN FROM PUB - OG REVIEW QUERY
Sep 14, 2012 PBCR
LAW OFFICE PUBLICATION REVIEW COMPLETED
Sep 6, 2012 PREV
EXPARTE APPEAL TERMINATED
Sep 5, 2012 EXPT
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 5, 2012 CNSA
EXAMINERS AMENDMENT MAILED
Sep 5, 2012 CNEA
EXAMINER'S AMENDMENT ENTERED
Sep 5, 2012 XAEC
EXAMINERS AMENDMENT -WRITTEN
Sep 5, 2012 CNEA
UNDELIVERABLE MAIL - NO ACTION TAKEN
Jul 31, 2012 UNDN
ACTION DENYING REQ FOR RECON MAILED
Jul 16, 2012 RECD
ACTION CONTINUING FINAL - COMPLETED
Jul 16, 2012 CNCF
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Jun 28, 2012 ERFR
EX PARTE APPEAL-INSTITUTED
Jun 28, 2012 EXPI
JURISDICTION RESTORED TO EXAMINING ATTORNEY
Jun 28, 2012 JURT
EXPARTE APPEAL RECEIVED AT TTAB
Jun 28, 2012 EXAF
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Feb 29, 2012 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Feb 29, 2012 OPNR
FINAL REFUSAL MAILED
Dec 28, 2011 CNFR
FINAL REFUSAL WRITTEN
Dec 28, 2011 CNFR
NON-FINAL ACTION MAILED
Jun 29, 2011 CNRT
NON-FINAL ACTION WRITTEN
Jun 29, 2011 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 7, 2011 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 7, 2011 CRFA
ASSIGNED TO LIE
May 18, 2011 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 12, 2011 TROA
REFUSAL PROCESSED BY IB
Dec 4, 2010 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Nov 12, 2010 RFCS
REFUSAL PROCESSED BY MPU
Nov 12, 2010 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Nov 11, 2010 RFCR
NON-FINAL ACTION WRITTEN
Nov 10, 2010 CNRT
ASSIGNED TO EXAMINER
Nov 5, 2010 DOCK
APPLICATION FILING RECEIPT MAILED
Sep 28, 2010 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 24, 2010 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Sep 23, 2010 REPR